CALM Stock Analysis: Cal-Maine Foods | NASDAQ
Farm Products | NASDAQ, USA | Market Cap: 2.970m USD | 12M Return: -30.7% | US1280302027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 97.6M
EPS Trend: -11.0%
Qual. Beats: 0
Rev. Trend: 40.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cal-Maine Foods, Inc. (NASDAQ: CALM) is a U.S. producer and distributor of shell eggs, egg products, and prepared foods, operating through three segments: Conventional Shell Eggs, Specialty Shell Eggs, and Prepared Foods. The company offers specialty offerings such as cage-free, organic, brown, free-range, pasture-raised, and nutritionally enhanced eggs, alongside conventional and co-pack shell eggs, as well as prepared items including pre-cooked egg patties, omelets, hard-cooked eggs, pancakes, waffles, and specialty wraps.
The company markets products under brands including Egg-Lands Best, Land O Lakes, Farmhouse Eggs, Sunups, 4Grain, Vans, MeadowCreek Foods, and Crepini, selling to national and regional grocery chains, club stores, independent supermarkets, foodservice distributors, and egg product consumers. Founded in 1957, Cal-Maine is headquartered in Ridgeland, Mississippi, and has been publicly traded since its 1996 IPO.
Cal-Maine operates within the Consumer Staples sector (Packaged Foods & Meats sub-industry), where egg producers typically benefit from stable, recurring demand driven by eggs role as an affordable, everyday protein source. The U.S. shell egg industry is highly consolidated, with a small number of large producers accounting for the majority of commercial supply.
- Avian flu outbreaks tighten shell egg supply and prices
- Cage-free egg mandates lift specialty segment pricing power
- Corn and soybean meal costs pressure conventional egg margins
| Net Income: 58.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -39.07 > 1.0 |
| NWC/Revenue: 50.65% < 20% (prev 35.85%; Δ 14.80% < -1%) |
| CFO/TA 0.03 > 3% & CFO 103.0m > Net Income 58.7m |
| Net Debt (-766.1m) to EBITDA (145.5m): -5.27 < 3 |
| Current Ratio: 7.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.7m) vs 12m ago -3.55% < -2% |
| Gross Margin: 14.28% > 18% (prev 43.54%; Δ -29.25% > 0.5%) |
| Asset Turnover: 81.44% > 50% (prev 137.6%; Δ -56.17% > 0%) |
| Interest Coverage Ratio: 31.03 > 6 (EBIT TTM 17.3m / Interest Expense TTM 556k) |
| A: 0.43 (Total Current Assets 1.47b - Total Current Liabilities 191.1m) / Total Assets 3.01b |
| B: 0.90 (Retained Earnings 2.71b / Total Assets 3.01b) |
| C: 0.01 (EBIT TTM 17.3m / Avg Total Assets 3.10b) |
| D: 5.93 (Book Value of Equity 2.57b / Total Liabilities 433.4m) |
| Altman-Z'' = 11.98 = AAA |
| DSRI: 2.02 (Receivables 285.2m/245.9m, Revenue 2.53b/4.40b) |
| GMI: 3.05 (GM 43.54% / 14.28%) |
| AQI: 1.58 (AQ_t 0.08 / AQ_t-1 0.05) |
| SGI: 0.57 (Revenue 2.53b / 4.40b) |
| TATA: -0.01 (NI 58.7m - CFO 103.0m) / TA 3.01b) |
| Beneish M = -0.30 (Cap -4..+1) = D |
As of October 18, 2026, the stock is trading at USD 63.65 with a total of 1,022,284 shares traded. Over the past week, the price has changed by -1.09%, over one month by -14.09%, over three months by -28.12% and over the past year by -30.71%.
Current recommended Stop Loss: 60.50 (which is 4.9% or 1.3 ATR below the current price).
Cal-Maine Foods has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold CALM.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 68.3 | 7.4% |
P/E Trailing = 50.872
P/E Forward = 19.802
P/S = 1.1747
P/B = 1.2974
P/EG = 2.1983
Revenue TTM = 2.53b USD
EBIT TTM = 17.3m USD
EBITDA TTM = 145.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.44m USD (Leases only: 1.44m)
Net Debt = -766.1m USD (calculated: Debt 1.44m - CCE 767.6m)
Enterprise Value = 2.20b USD (2.97b + Debt 1.44m - CCE 767.6m)
Interest Coverage Ratio = 31.03 (Ebit TTM 17.3m / Interest Expense TTM 556k)
EV/FCF = -74.67x (Enterprise Value 2.20b / FCF TTM -29.5m)
FCF Yield = -1.34% (FCF TTM -29.5m / Enterprise Value 2.20b)
FCF Margin = -1.17% (FCF TTM -29.5m / Revenue TTM 2.53b)
Net Margin = 2.32% (Net Income TTM 58.7m / Revenue TTM 2.53b)
Gross Margin = 14.28% ((Revenue TTM 2.53b - Cost of Revenue TTM 2.17b) / Revenue TTM)
Gross Margin QoQ = 0.07% (prev 6.16%)
Tobins Q-Ratio = 0.73 (Enterprise Value 2.20b / Total Assets 3.01b)
Interest Expense / Debt = 38.53% (Interest Expense 556k / Debt 1.44m)
Taxrate = 14.61% (10.7m / 73.5m)
NOPAT = 14.7m (EBIT 17.3m * (1 - 14.61%))
Current Ratio = 7.70 (Total Current Assets 1.47b / Total Current Liabilities 191.1m)
Debt / Equity = 0.00 (Debt 1.44m / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = -5.27 (Net Debt -766.1m / EBITDA 145.5m)
Debt / FCF = 25.96 (negative FCF - burning cash) (Net Debt -766.1m / FCF TTM -29.5m)
Total Stockholder Equity = 2.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 58.7m / Total Assets 3.01b)
RoE = 2.22% (Net Income TTM 58.7m / Total Stockholder Equity 2.65b)
RoCE = 0.61% (EBIT 17.3m / Capital Employed (Total Assets 3.01b - Current Liab 191.1m))
RoIC = 0.55% (NOPAT 14.7m / Invested Capital 2.70b)
WACC = 4.36% (E(2.97b)/V(2.97b) * Re(4.35%) + D(1.44m)/V(2.97b) * Rd(38.53%) * (1-Tc(0.15)))
Discount Rate = 4.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.43 | Cagr: -2.02%
[DCF] Fair Price = unknown (Cash Flow -29.5m)
EPS Correlation: -11.01 | EPS CAGR: -10.24% | SUE: -0.68 | # QB: 0
Revenue Correlation: 40.09 | Revenue CAGR: 11.09% | SUE: -0.19 | # QB: 0
EPS current Quarter (2026-11-30): EPS=-1.00 | Chg30d=-364.47% | Revisions=-40% | Analysts=2
EPS next Quarter (2027-02-28): EPS=-0.56 | Chg30d=-157.81% | Revisions=-40% | Analysts=2
EPS current Year (2027-05-31): EPS=-2.98 | Chg30d=-308.01% | Revisions=-40% | GrowthEPS=-145.9% | GrowthRev=-20.2%
EPS next Year (2028-05-31): EPS=1.01 | Chg30d=-71.69% | Revisions=-40% | GrowthEPS=+134.0% | GrowthRev=+12.4%
[Analyst] Revisions Ratio: -73% (up=0, down=8)